SEC Company Response from Tempest Therapeutics, Inc. (TPST) (CIK 0001544227) (TPST) — Nov 1, 2018
Tempest Therapeutics, Inc. (TPST) (CIK 0001544227)
Date: Nov. 1, 2018 · CIK: 0001544227 · Accession: 0001104659-18-065524
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227547
Letter
OvaScience, Inc.
9 Fourth Avenue
Waltham, Massachusetts 02451
November 1, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
RE: OvaScience, Inc.
Registration Statement on Form S-4 File No. 333-227547
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, OvaScience, Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-227547), as amended (the “Registration Statement”), so that it may become effective at 10:00 a.m. Washington, D.C. time on November 5, 2018, or as soon as possible thereafter.
The Company hereby authorizes Megan N. Gates, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Attorney Gates at (617) 348-4443 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Attorney Gates.
Very truly yours,
OVASCIENCE, INC.
Show Raw Text
CORRESP 1 filename1.htm OvaScience, Inc. 9 Fourth Avenue Waltham, Massachusetts 02451 November 1, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: OvaScience, Inc. Registration Statement on Form S-4 File No. 333-227547 Request for Acceleration of Effectiveness Ladies and Gentlemen: In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, OvaScience, Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-227547), as amended (the “Registration Statement”), so that it may become effective at 10:00 a.m. Washington, D.C. time on November 5, 2018, or as soon as possible thereafter. The Company hereby authorizes Megan N. Gates, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration. The Company respectfully requests that it be notified of such effectiveness by a telephone call to Attorney Gates at (617) 348-4443 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Attorney Gates. Very truly yours, OVASCIENCE, INC. /s/ Jonathan Gillis Jonathan Gillis Senior Vice President, Finance cc: OvaScience, Inc. Christopher A. Kroeger., M.D., M.B.A., President and Chief Executive Officer Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. William C. Hicks, Esq. Megan N. Gates, Esq. Daniel A. Bagliebter, Esq. Cooley, LLP Miguel J. Vega, Esq. Nicole Brookshire, Esq.